Eloísa Jantus-Lewintre

18PUBLICATIONS
64CO-AUTHORS
Molecular targetsInnate immunityPredictive and prognostic markersOral medicine and pathologyLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 01, 2025
High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models.

Juan Carlos Álvarez-Pérez, Juan Sanjuán-Hidalgo, Alberto M Arenas

|Nov 03, 2024
G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1.

Francisco Exposito, Miriam Redrado, Diego Serrano

|May 14, 2024
HMGB1 Expression Levels Correlate with Response to Immunotherapy in Non-Small Cell Lung Cancer.

Maria González-Cao, Xueting Cai, Jilian Wilhelmina Paulina Bracht

|Dec 23, 2023
Circulating Immune Proteins: Improving the Diagnosis and Clinical Outcome in Advanced Non-Small Cell Lung Cancer.

Susana Torres-Martínez, Silvia Calabuig-Fariñas, Sandra Gallach

|Oct 10, 2023
Signature-driven repurposing of Midostaurin for combination with MEK1/2 and KRASG12C inhibitors in lung cancer.

Irati Macaya, Marta Roman, Connor Welch

|Aug 11, 2023
Soluble galectin-3 as a microenvironment-relevant immunoregulator with prognostic and predictive value in lung adenocarcinoma.

Susana Torres-Martínez, Silvia Calabuig-Fariñas, Andrea Moreno-Manuel

Pageof 3

Frequent Collaborators

8 joint publications

Silvia Calabuig-Fariñas

5 joint publications

Rafael Sirera

5 joint publications

Carlos Camps

4 joint publications

Andrea Moreno-Manuel